What is Amarasate? Calocurb's hop extract, claim by claim
What is Amarasate? The New Zealand bitter hop extract inside Calocurb, with each brand claim set against the four human trials we read.
What is Amarasate? The New Zealand bitter hop extract inside Calocurb, with each brand claim set against the four human trials we read.
Calocurb is a supplement with one 24-week, 150-person trial (4.3% vs 0.5%). Ozempic is an FDA-approved diabetes drug with a boxed warning. Side by side.
Calocurb side effects, counted: the 24-week C4 trial's withdrawals and dose cuts for diarrhea and nausea, set against the brand pages' 'rare' and 'mild'.
Yes: one 24-week placebo-controlled trial, company-funded. Calocurb lost 4.3% vs 0.5% on placebo, a 3.8-point gap, at the label's maximum dose.
FDA published a company announcement of a nationwide voluntary recall of Lipofit Extreme Fat Burner 2.0 over undeclared fluoxetine and 2,4-dinitrophenol. Two undeclared substances, two very different kinds of failure.
Holland and Barrett's new own-label sachet is built on a fibre complex with a real open-access human trial behind it. That trial ran 150 minutes and never weighed anybody.
The FDA notified consumers about Esbelta Intense Loss and Esbelta Chupapanza Flat Belly on 18 August. This is not substitution and it is not underdosing — it is undeclared pharmaceutical ingredients, which no amount of label arithmetic would have caught.
Reported on 12 August: three more online weight-loss products added to the FDA's yellow oleander alert, which now runs to 25. The failure here is not a dose problem — it is that the plant in the capsule was not the plant on the label.